TIAA CREF INVESTMENT MANAGEMENT LLC - RETROPHIN INC ownership

RETROPHIN INC's ticker is RTRX and the CUSIP is 761299106. A total of 123 filers reported holding RETROPHIN INC in Q4 2016. The put-call ratio across all filers is 0.30 and the average weighting 0.3%.

Quarter-by-quarter ownership
TIAA CREF INVESTMENT MANAGEMENT LLC ownership history of RETROPHIN INC
ValueSharesWeighting
Q1 2019$7,853,000
-40.1%
347,017
-40.1%
0.01%
-40.0%
Q4 2018$13,111,000
-60.8%
579,376
-50.2%
0.01%
-9.1%
Q3 2018$33,414,000
+56.1%
1,163,044
+48.1%
0.01%
-21.4%
Q2 2018$21,403,000
+51.0%
785,129
+23.9%
0.01%
+40.0%
Q1 2018$14,171,000
+4.2%
633,766
-1.8%
0.01%
+11.1%
Q4 2017$13,601,000
-16.2%
645,519
-1.0%
0.01%
-18.2%
Q3 2017$16,230,000
+33.1%
652,052
+3.7%
0.01%
+22.2%
Q2 2017$12,193,000
+3.8%
628,811
-1.2%
0.01%
+12.5%
Q1 2017$11,751,000
+188.7%
636,545
+196.0%
0.01%
+166.7%
Q4 2016$4,071,000
-17.4%
215,030
-2.4%
0.00%0.0%
Q3 2016$4,929,000
+72.2%
220,250
+37.0%
0.00%
+50.0%
Q2 2016$2,863,000
+65.5%
160,757
+26.9%
0.00%
+100.0%
Q1 2016$1,730,000
-29.2%
126,6410.0%0.00%
-50.0%
Q4 2015$2,443,000
-8.3%
126,641
-3.7%
0.00%0.0%
Q3 2015$2,665,000
-41.3%
131,519
-4.0%
0.00%
-33.3%
Q2 2015$4,542,000
+90.8%
137,028
+37.9%
0.00%
+50.0%
Q1 2015$2,381,000
+116.7%
99,376
+10.7%
0.00%
+100.0%
Q4 2014$1,099,000
-10.0%
89,768
-33.7%
0.00%0.0%
Q3 2014$1,221,000
-34.3%
135,389
-14.5%
0.00%0.0%
Q2 2014$1,858,000
+23.0%
158,259
+122.8%
0.00%0.0%
Q1 2014$1,511,00071,0170.00%
Other shareholders
RETROPHIN INC shareholders Q4 2016
NameSharesValueWeighting ↓
Consonance Capital Management LP 4,032,123$91,247,0006.71%
SCOPIA CAPITAL MANAGEMENT LP 5,910,853$133,763,0004.54%
Ghost Tree Capital, LLC 500,000$11,315,0004.11%
Broadfin Capital, LLC 1,016,114$22,995,0003.02%
Perceptive Advisors 3,342,038$49,782,0001.90%
EMORY UNIVERSITY 92,940$2,103,0001.66%
FALCON POINT CAPITAL, LLC 80,378$1,819,0001.09%
Tavio Capital LLC 100,985$2,285,0000.95%
SPHERA FUNDS MANAGEMENT LTD. 325,678$7,370,0000.83%
OAK RIDGE INVESTMENTS LLC 281,119$6,362,0000.46%
View complete list of RETROPHIN INC shareholders